Cefazolin for Injection USP and Dextrose Injections USP recall: Particulate Matter
Cefazolin for Injection USP and Dextrose Injections USP, 1 g in Duplex, 50 mL Container, Catalog Number 3103-11, For IV Use Only, Sterile, Single…
Why was Cefazolin for Injection USP and Dextrose Injections USP recalled?
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot# H2S725, H2S726, Exp 07/14; H3D724, Exp 11/14; H3E724, Exp 12/14; Lot# H3H507, Exp 01/15
- Product
- Cefazolin for Injection USP and Dextrose Injections USP, 1 g in Duplex, 50 mL Container, Catalog Number 3103-11, For IV Use Only, Sterile, Single…
- Recalling firm
- B. Braun Medical Inc
- Quantity
- 136,392 units
- Distribution
- Nationwide, Puerto Rico and Spain
- Recall date
- May 7, 2014
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)